Beyond 10-year risk: a cost-effectiveness analysis of statins for the primary prevention of cardiovascular disease.

Circulation. 2022;145:1312-1323

Kohli-Lynch CN, Lewsey J, Boyd KA, French DD, Jordan N, Moran AE, Sattar N, Preiss D, Briggs AH